The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies

The goal of the AntiBotABE Program was the development of recombinant antibodies that neutralize botulinum neurotoxins (BoNT) A, B and E. These serotypes are lethal and responsible for most human botulinum cases. To improve therapeutic efficacy, the heavy and light chains (HC and LC) of the three Bo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Toxins (Basel)
Main Authors: Rasetti-Escargueil, Christine, Avril, Arnaud, Miethe, Sebastian, Mazuet, Christelle, Derman, Yagmur, Selby, Katja, Thullier, Philippe, Pelat, Thibaut, Urbain, Remi, Fontayne, Alexandre, Korkeala, Hannu, Sesardic, Dorothea, Hust, Michael, Popoff, Michel R.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5666356/
https://ncbi.nlm.nih.gov/pubmed/28974033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins9100309
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados